New award for synthesis of non-GMP small molecules, funding to cover work assignment 1.

Ended Definitive Contract Awarded Last action

Contract number
HHSN261201200012C
Awardee
Awarding agency
Obligated
$2,027,623

Award facts

Opportunity
Contract value 27% obligated
  • $2,027,623.41 Current, with exercised options
  • $7,542,381.41 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 9 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Santa Fe, FL 32615, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00032 -$169
Supplemental Agreement for work within scope P00031 -$198
Supplemental Agreement for work within scope P00030 -$147
Supplemental Agreement for work within scope P00029 -$51
Supplemental Agreement for work within scope 28 · Synthesis of non-GMP small molecules period of performance from 5/21/2012-5/20/2017 -$108,691
Supplemental Agreement for work within scope 27 · Synthesis of non-GMP molecules $192,026
Supplemental Agreement for work within scope 26 -$10,671
Exercise an Option 25 $59,586
Supplemental Agreement for work within scope 24 $72,854
Supplemental Agreement for work within scope 23 $28,730
Supplemental Agreement for work within scope 22 $59,586
Other Administrative Action 21 $0
Other Administrative Action 20 $0
Supplemental Agreement for work within scope 19 $383,651
Funding Only Action 18 $78,650
Funding Only Action 17 $30,565
Funding Only Action 16 $73,580
Funding Only Action 15 $34,068
Funding Only Action 14 $31,913
Funding Only Action 13 · Synthesis of non-GMP small molecules $25,565
Funding Only Action 12 $81,645
Other Administrative Action 11 $0
Funding Only Action 10 $403,659
Funding Only Action 9 $41,847
Funding Only Action 8 $17,156
Supplemental Agreement for work within scope 7 $102,615
Funding Only Action 6 $13,445
Other Administrative Action 5 $0
Other Administrative Action 4 · Other functions this modification corrects orders breakdown as listed in article b.2. $0
Other Administrative Action 3 · Other functions this modification restructures the contract to an IDIQ contract with fully funded orders. $0
Funding Only Action 2 · Other functions this modification adds funding for WA 4 and modifies section b. $298,125
Funding Only Action 1 · Other functions ; this modification adds funding for WA's 2 and 3, and modifies sections g and i. $43,285
Original award $75,000
Show all 33

About this award

Written by GovTribe AI ·

The National Cancer Institute awarded a definitive contract to Alchem Laboratories Corporation for synthesis of non-GMP small molecules on May 21, 2012, under a total small business set-aside, with a ceiling value of $7,542,381.41.

The originating solicitation covers synthesis of non-GMP small molecules for Work Assignment 1. Place of performance is Alachua, FL. The period of performance runs from May 21, 2012 through May 20, 2017, with ultimate completion on July 7, 2017. The contract is priced on a cost-plus-fixed-fee basis.

Quick answers

Who was awarded contract HHSN261201200012C?

HHSN261201200012C was awarded to Alchem Laboratories Corporation by National Cancer Institute (National Institutes of Health) on May 21, 2012.

How much is contract HHSN261201200012C worth?

The government has obligated $2,027,623 on HHSN261201200012C. Its potential value, with all options, is $7,542,381.

Was contract HHSN261201200012C competed?

The extent of competition for HHSN261201200012C was full and open competition after exclusion of sources. The government received 9 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login